Harm Reduction Therapeutics Marks International Overdose Awareness Day with Free Donations of RiVive™ Life-Saving Over-the-Counter Naloxone Nasal Spray by Jim Kelly | Sep 3, 2024 | News
A2A Alliance Pharmaceuticals and Harm Reduction Therapeutics Announce Strategic Partnership to Expand Access to Life-Saving OTC Naloxone 3mg Nasal Spray (RiVive™) to U.S. Federal Entities and Veterans by Jim Kelly | Aug 14, 2024 | News
A new, cheaper naloxone is coming to pharmacy shelves, funded in part by Purdue Pharma’s bankruptcy by Jim Kelly | Aug 17, 2023 | News
Harm Reduction Therapeutics and Catalent Sign Commercial Supply Agreement for Naloxone Nasal Spray by Jim Kelly | Mar 24, 2023 | News